menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Biolinq

Develops a wearable biosensor patch that continuously monitors glucose levels through electrochemical sensors, providing real-time feedback.

Biosplice

Developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing.

Blackrock Neurotech

Neurotechnology company providing brain-computer interface solutions.

Blink Health

Digital healthcare platform connecting patients to pharmacies and manufacturers for discounted prescription medications and transparent pricing.

BostonGene

Advances personalized medicine and precision oncology by providing insights into the molecular profile of cancer.

Boulder

Digital platform delivers medication-assisted addiction treatment and specialist support through telehealth services.

BrainCo

Develops neurotechnology that enables cognitive enhancement and intuitive control through brain-computer interfaces.

Brightseed

Discovers plant-based bioactive compounds to enhance health, providing sustainable solutions for food, beverage, and wellness.

Brook

Combines AI-powered tools, connected devices, and remote clinical teams to deliver personalized, continuous care for individuals with chronic conditions.

CaaMTech

Pharmaceutical company develops novel psychedelic-inspired therapeutics targeting serotonin receptors to advance mental health treatments.

Cajal Neuroscience

Discovers drug targets for neurodegenerative diseases using advanced microscopy and genomics to develop treatments for brain disorders.

Cala Health

Creates wearable neuromodulation devices for non-invasive, personalized therapies to manage chronic conditions.

Calm-Logo

Calm

Application for mindfulness and wellness designed to reduce stress and anxiety.

Cambrian Bio

Clinical-stage drug development company.

CAMP4

Specializes in programmable RNA-based therapeutics, which aim to provide targeted treatments for a variety of complex diseases.

Candid Therapeutics

Develops innovative therapies that utilize T-cell engager antibodies to selectively eliminate autoreactive B-cells, aiming to provide deeper and more durable therapeutic effects for autoimmune diseases.

Capital Rx

Healthcare technology company that manages pharmacy benefits.

Capstan Therapeutics-Logo

Capstan

In vivo engineering of cells through targeted lipid nanoparticles.